Literature DB >> 35737392

Alarm Burden in Infants With Bronchopulmonary Dysplasia Monitored With Pulse Oximetry at Home.

Heidi M Herrick1,2, Molly Passarella3, James Weimer4, Christopher P Bonafide1,5, Sara B DeMauro1,2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35737392      PMCID: PMC9227001          DOI: 10.1001/jamanetworkopen.2022.18367

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


× No keyword cloud information.

Introduction

Approximately half of extremely preterm infants have bronchopulmonary dysplasia (BPD).[1] One-quarter of these infants are prescribed home oxygen,[2] yet compliance with home pulse oximetry is low.[3] Despite parental reports of frequent alarms contributing to premature monitor discontinuation,[4] limited data exist to inform home alarm configuration and reduce unnecessary alarms. In a small observational study of a heterogenous pediatric population, longer alarm delays were associated with decreased alarm incidence.[5] The true burden of home oximeter alarms and the impact of alarm parameters on alarm incidence are unknown in patients with BPD. Our objective was to evaluate the association of low oxygen saturation (Spo2) limits, alarm delays, and averaging times with alarm incidence by simulating threshold adjustments using data from a clinical trial of continuous home Spo2 monitoring among infants with BPD.

Methods

The BPD Saturation Targeting Trial is an ongoing randomized clinical trial (NCT03385330) in which preterm infants with moderate or severe BPD undergo Spo2 monitoring (Masimo Rad-8) while asleep from 34 to 44 weeks’ postmenstrual age (PMA) to 6 months’ corrected age. In this secondary study, we used home oximeter data acquired during the first 4 weeks after discharge. Patients with 8 hours or more of usable data were included. Because no events requiring emergency intervention were reported while patients were on study monitors, all Spo2 readings of zero were considered artifact and excluded from analysis. We used the raw data to estimate counts of low Spo2 alarms that would occur with Spo2 limits of 80%, 85%, and 90%; alarm delays of 0, 5, 10, and 15 seconds; and averaging times of 8 and 16 seconds. We tested for linear trends in the rate of alarms per 8 hours (to estimate number of alarms per night) using the Cuzick test. Parents provided written informed consent for enrollment in this study approved by the Children’s Hospital of Philadelphia institutional review board. This study followed the STROBE reporting guideline.

Results

Twenty infants with mean (SD) discharge PMA of 47.4 (5.2) weeks were included (Table). The Figure depicts the estimated number of alarms per 8 hours across Spo2 limits and alarm delays with 8- and 16-second averaging times. Under typical postdischarge oximeter settings at our institution (90% limit, 0-second delay, 8-second averaging time), patients would experience a median (IQR) of 23.1 (16.0-53.0) alarms per 8 hours. Patients would experience a median of less than 1 alarm per 8 hours with an Spo2 limit of 80%, 15-second delay, and averaging time of 8 or 16 seconds. Within each delay, lower Spo2 limits were associated with lower alarm rates for both 8- and 16-second averaging times (P < .001). Within a given Spo2 limit, longer alarm delays were associated with lower alarm rates (8-s averaging time: P < .001 for all Spo2 limits; 16-s averaging time: 80%, P < .001; 85%, P = .001; 90%, P = .003). With a 0-s delay and a 90% Spo2 limit, there was no significant difference in alarms per 8 hours between 8- and 16- second averaging times.
Table.

Patient Characteristics

CharacteristicPatients, No. (%) (N = 20)
Birth gestational age, mean (SD), wk26.1 (1.9)
Severity of BPDa
Moderate1 (5)
Severe19 (95)
PMA at hospital discharge, mean (SD), wk47.4 (5.2)
Respiratory support at hospital discharge
Nasal cannula10 (50)
Room air10 (50)
Length of monitoring, mean (SD), hb114.9 (80.7)

Abbreviations: BPD, bronchopulmonary dysplasia; PMA, postmenstrual age.

BPD severity defined according to 2001 Jobe and Bancalari National Institutes of Health Workshop. Moderate BPD was defined as 28 days of oxygen plus fraction of inspired oxygen of less than 30% at 36 weeks’ PMA or discharge; severe, 28 days of oxygen plus fraction of inspired oxygen of 30% or greater and/or positive pressure at 36 weeks’ PMA or discharge.

Length of nonzero oxygen saturation monitoring.

Figure.

Low Oxygen Saturation (Spo2) Alarms Across Various Saturation Thresholds and Alarm Delays

The boxes represent the IQRs, with the horizontal lines indicating the medians. Whiskers indicate the ranges.

Abbreviations: BPD, bronchopulmonary dysplasia; PMA, postmenstrual age. BPD severity defined according to 2001 Jobe and Bancalari National Institutes of Health Workshop. Moderate BPD was defined as 28 days of oxygen plus fraction of inspired oxygen of less than 30% at 36 weeks’ PMA or discharge; severe, 28 days of oxygen plus fraction of inspired oxygen of 30% or greater and/or positive pressure at 36 weeks’ PMA or discharge. Length of nonzero oxygen saturation monitoring.

Low Oxygen Saturation (Spo2) Alarms Across Various Saturation Thresholds and Alarm Delays

The boxes represent the IQRs, with the horizontal lines indicating the medians. Whiskers indicate the ranges.

Discussion

We used patient-level data to demonstrate the burden of low Spo2 alarms among infants with BPD who are monitored at home. Furthermore, we showed the association of alarm parameters with alarm incidence. Current science suggests prolonged—but not necessarily brief—intermittent hypoxemia episodes with an Spo2 below 80% are associated with poor developmental outcomes in convalescing extremely preterm infants.[6] Broadening Spo2 limits and/or adding alarm delays can significantly decrease alarm rates while preserving alarms for episodes of potentially critical hypoxemia. Typical home oximeter settings (90% limit, 0-s delay) seem to create an untenable alarm burden for caregivers. Study limitations include sample size and use of simulated alarms. Future studies need to assess the outcome of liberalizing home parameters to reduce alarm rates, which may include more uninterrupted sleep, decreased caregiver alarm fatigue, and improved compliance with home monitoring to optimize health and developmental outcomes.
  6 in total

1.  The History of Home Cardiorespiratory Monitoring.

Authors:  Gary E Freed; Francis Martinez
Journal:  Pediatr Ann       Date:  2017-08-01       Impact factor: 1.132

2.  Factors that influence use of a home cardiorespiratory monitor for infants: the collaborative home infant monitoring evaluation.

Authors:  Jean M Silvestri; George Lister; Michael J Corwin; Sheilah M Smok-Pearsall; Terry M Baird; David H Crowell; Jean Cantey-Kiser; Carl E Hunt; Larry Tinsley; Paula H Palmer; Rebecca S Mendenhall; Toke T Hoppenbrouwers; Michael R Neuman; Debra E Weese-Mayer; Marian Willinger
Journal:  Arch Pediatr Adolesc Med       Date:  2005-01

3.  Prolonged, documented home-monitoring of oxygenation in infants and children.

Authors:  Jean-François Gélinas; G Michael Davis; Cheryl Arlegui; Aurore Côté
Journal:  Pediatr Pulmonol       Date:  2008-03

4.  Association Between Intermittent Hypoxemia or Bradycardia and Late Death or Disability in Extremely Preterm Infants.

Authors:  Christian F Poets; Robin S Roberts; Barbara Schmidt; Robin K Whyte; Elizabeth V Asztalos; David Bader; Aida Bairam; Diane Moddemann; Abraham Peliowski; Yacov Rabi; Alfonso Solimano; Harvey Nelson
Journal:  JAMA       Date:  2015-08-11       Impact factor: 56.272

5.  Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018.

Authors:  Edward F Bell; Susan R Hintz; Nellie I Hansen; Carla M Bann; Myra H Wyckoff; Sara B DeMauro; Michele C Walsh; Betty R Vohr; Barbara J Stoll; Waldemar A Carlo; Krisa P Van Meurs; Matthew A Rysavy; Ravi M Patel; Stephanie L Merhar; Pablo J Sánchez; Abbot R Laptook; Anna Maria Hibbs; C Michael Cotten; Carl T D'Angio; Sarah Winter; Janell Fuller; Abhik Das
Journal:  JAMA       Date:  2022-01-18       Impact factor: 157.335

6.  Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT).

Authors:  Timothy P Stevens; Neil N Finer; Waldemar A Carlo; Peter G Szilagyi; Dale L Phelps; Michele C Walsh; Marie G Gantz; Abbot R Laptook; Bradley A Yoder; Roger G Faix; Jamie E Newman; Abhik Das; Barbara T Do; Kurt Schibler; Wade Rich; Nancy S Newman; Richard A Ehrenkranz; Myriam Peralta-Carcelen; Betty R Vohr; Deanne E Wilson-Costello; Kimberly Yolton; Roy J Heyne; Patricia W Evans; Yvonne E Vaucher; Ira Adams-Chapman; Elisabeth C McGowan; Anna Bodnar; Athina Pappas; Susan R Hintz; Michael J Acarregui; Janell Fuller; Ricki F Goldstein; Charles R Bauer; T Michael O'Shea; Gary J Myers; Rosemary D Higgins
Journal:  J Pediatr       Date:  2014-04-13       Impact factor: 4.406

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.